story of the week
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial
JAMA 2024 Mar 19;331(11)920-929, TG Simon, RM Wilechansky, S Stoyanova, A Grossman, LE Dichtel, GM Lauer, KK Miller, Y Hoshida, KE Corey, R Loomba, RT Chung, AT ChanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.